I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Nemunaitis, J.
347
results:
Search for persons
X
Format
Online (347)
Mediatypes
Articles (Online) (263)
OpenAccess-fulltext (84)
Sorted by: Relevance
Sorted by: Year
?
1
Randomized double-blind placebo-controlled trial of primary..:
Rocconi, R.P.
;
Chan, J.K.
;
Barve, M.
...
Gynecologic Oncology. 159 (2020) - p. 51-52 , 2020
Link:
https://doi.org/10.1016/..
?
2
Phase I trial of Vigil® personalized engineered autologous ..:
Rocconi, R.P.
;
Scalici, J.M.
;
Barve, M.
...
Gynecologic Oncology. 149 (2018) - p. 40-41 , 2018
Link:
https://doi.org/10.1016/..
?
3
Pharmacokinetics (PK) of alisertib (MLN8237) in adult patie..:
Zhou, X.
;
Lockhart, A.C.
;
Fu, S.
...
European Journal of Cancer. 69 (2016) - p. S115-S116 , 2016
Link:
https://doi.org/10.1016/..
?
4
366 Effects of rifampin, a strong metabolic enzyme inducer,..:
Zhou, X.
;
Pant, S.
;
Sarantopoulos, J.
...
European Journal of Cancer. 51 (2015) - p. S76 , 2015
Link:
https://doi.org/10.1016/..
?
5
3335 Intralesional administration of Coxsackievirus A21 (CV..:
Andtbacka, R.H.I.
;
Curti, B.
;
Kaufman, H.L.
...
European Journal of Cancer. 51 (2015) - p. S676-S677 , 2015
Link:
https://doi.org/10.1016/..
?
6
367 Effects of alisertib (MLN8237), an investigational Auro..:
Zhou, X.
;
Nemunaitis, J.
;
Pant, S.
...
European Journal of Cancer. 51 (2015) - p. S76-S77 , 2015
Link:
https://doi.org/10.1016/..
?
7
3334 Durable complete responses (CR) in patients (pts) with..:
Andtbacka, R.H.I.
;
Kaufman, H.
;
Collichio, F.
...
European Journal of Cancer. 51 (2015) - p. S676 , 2015
Link:
https://doi.org/10.1016/..
?
8
A phase III study of belagenpumatucel-L, an allogeneic tumo..:
Giaccone, G.
;
Bazhenova, L.A.
;
Nemunaitis, J.
...
European Journal of Cancer. 51 (2015) 16 - p. 2321-2329 , 2015
Link:
https://doi.org/10.1016/..
?
9
3110 Safety and clinical activity of avelumab (MSB0010718C)..:
Hassan, R.
;
Thomas, A.
;
Patel, M.
...
European Journal of Cancer. 51 (2015) - p. S639 , 2015
Link:
https://doi.org/10.1016/..
?
10
Randomized phase II trial of maintenance autologous tumor c..:
Oh, J.
;
Barve, M.
;
Grosen, E.A.
...
Gynecologic Oncology. 137 (2015) - p. 2-3 , 2015
Link:
https://doi.org/10.1016/..
?
11
501 Immunological STAT3 knockdown associated with anti-tumo..:
McCoon, P.
;
Woessner, R.
;
DuPont, R.
...
European Journal of Cancer. 50 (2014) - p. 163-164 , 2014
Link:
https://doi.org/10.1016/..
?
12
Immune Response Plays an Important Role in KRASG12D Induced..:
Yu, J.
;
Wu, J.
;
Liu, S.
...
Journal of Surgical Research. 186 (2014) 2 - p. 502 , 2014
Link:
https://doi.org/10.1016/..
?
13
50 The effect of esomeprazole, a proton pump inhibitor, on ..:
Zhou, X.
;
Nemunaitis, J.
;
Pant, S.
...
European Journal of Cancer. 50 (2014) - p. 21-22 , 2014
Link:
https://doi.org/10.1016/..
?
14
A Phase I Trial of Oral Ridaforolimus (AP23573; MK-8669) in..:
Nemunaitis, J.
;
Hochster, H.S.
;
Lustgarten, S.
...
Clinical Oncology. 25 (2013) 6 - p. 336-342 , 2013
Link:
https://doi.org/10.1016/..
?
15
A Novel PDX-1-Specific, Synthetic Promoter Driving Systemic..:
Liu, S.
;
Zhou, G.
;
Shahi, K.M.
...
Journal of Surgical Research. 179 (2013) 2 - p. 193 , 2013
Link:
https://doi.org/10.1016/..
1-15